• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[心血管风险降低:一个国际项目的影响]

[Cardiovascular risk reduction: impact of an international project].

作者信息

Colle B, Brusaferro S

机构信息

Direzione Sanitaria A.S.S. n.3 Alto Friuli.

出版信息

Ann Ig. 2008 May-Jun;20(3 Suppl 1):43-8.

PMID:18773604
Abstract

The Euroaction project, promoted by European Society of Cardiology, aims to determine whether a nurse co-ordinated, multidisciplinary, family based preventive cardiology programme could help more patients and their families achieve the recommended European lifestyle, risk factor and therapeutic goals for cardiovascular disease prevention. EUROACTION was evaluated in a paired cluster randomized controlled trial, and the primary care branch included 6 European countries. Consecutive patients > 50 years and < 80 years, with no history of cardiovascular disease, were prospectively identified by the general practitioners with one of the following: (i) high total cardiovascular risk (HeartScore > or = 5% over 10 years, either now or when projected to age 60 years) and on no medical treatment for blood pressure, lipids or diabetes; (ii) on treatment with anti-hypertensive and/or lipid-lowering drug therapies started in the last year but with no diabetes; (iii) diagnosed with diabetes mellitus (treated by diet alone or with oral hypoglycaemic drug therapy and/or insulin) within the last three years in both intervention and usual care practices. All eligible high risk individuals and their partners were then invited by the nurse for an assessment of their lifestyle, risk factors and therapeutic management as soon as possible after identification. In the primary care intervention branch 1019 patients have been enrolled with no differences by sex and mean age 62, while in the control branch 1005 patients were recruited with mean age 63, female were 43%. The main results show that Intervention group (I) had a statistically significant improvement compared to Usual Care (UC) in the assumption of recommended quantity of fruit and vegetables (78.4% I vs 38.8% UC p=0.005), in the weight loss (weight loss > al 5% in subjects with BMI > 25 kg/m2) (16.5% I vs 6.8% UC p=0.005), in blood pressure control both in people specifically treated with drugs and untreated (respectively 52% I vs 35% UC p=0.04 and 65% Ivs 45% UC p=0.02), in reaching the European target for total cholesterol (Total Cholesterol < 5.0 mmol/l) during the study year (from 21.9% to 35.8% (I) absolute increase 12.7% (p=0.025) vs from 33% to 32.2% (UC)). No significant differences were found about change of smoking habits. The experimented intervention model based on a multidisciplinary approach and nurses leaded showed a good one year impact in reducing cardiovascular risk factors in high risk people. This model should be further tested in local contexts.

摘要

由欧洲心脏病学会推动的“欧洲行动”项目,旨在确定一项由护士协调的、多学科的、基于家庭的预防性心脏病学项目是否能帮助更多患者及其家人实现欧洲推荐的生活方式、危险因素及心血管疾病预防的治疗目标。“欧洲行动”在一项配对整群随机对照试验中进行了评估,初级保健分支涵盖6个欧洲国家。年龄在50岁以上且80岁以下、无心血管疾病史的连续患者,由全科医生通过以下情况之一进行前瞻性识别:(i)心血管总体风险高(10年内心脏风险评分≥5%,无论是现在还是预计到60岁时)且未接受过血压、血脂或糖尿病治疗;(ii)在过去一年开始接受抗高血压和/或降脂药物治疗但无糖尿病;(iii)在干预和常规护理实践中,过去三年内被诊断为糖尿病(仅通过饮食治疗或口服降糖药物治疗和/或胰岛素治疗)。所有符合条件的高危个体及其伴侣随后由护士邀请,在识别后尽快对其生活方式、危险因素和治疗管理进行评估。在初级保健干预分支中,已招募1019名患者,性别和平均年龄62岁无差异,而在对照分支中招募了1005名患者,平均年龄63岁,女性占43%。主要结果显示,与常规护理(UC)相比,干预组(I)在以下方面有统计学显著改善:摄入推荐量的水果和蔬菜(I组78.4% vs UC组38.8%,p = 0.005)、体重减轻(BMI>25 kg/m²的受试者体重减轻>5%)(I组16.5% vs UC组6.8%,p = 0.005)、接受药物治疗和未接受药物治疗的人群血压控制情况(分别为I组52% vs UC组35%,p = 0.04;I组65% vs UC组45%,p = 故02)、在研究年度达到欧洲总胆固醇目标(总胆固醇<5.0 mmol/L)(从21.9%升至35.8%(I组),绝对增加12.7%(p = 0.025) vs 从33%降至32.2%(UC组))。在吸烟习惯改变方面未发现显著差异。基于多学科方法且由护士主导的实验性干预模式,在降低高危人群心血管危险因素方面显示出良好的一年期效果。该模式应在当地环境中进一步测试。

相似文献

1
[Cardiovascular risk reduction: impact of an international project].[心血管风险降低:一个国际项目的影响]
Ann Ig. 2008 May-Jun;20(3 Suppl 1):43-8.
2
[Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].[2000年西班牙的胆固醇血症控制。心血管疾病预防工具。卫生与消费部、西班牙心脏病学会和西班牙动脉硬化学会]
Rev Esp Salud Publica. 2000 May-Jun;74(3):215-53.
3
Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.来自15个国家的冠心病患者的生活方式、危险因素管理及药物治疗的应用;欧洲心脏调查项目EUROASPIRE II的主要结果
Eur Heart J. 2001 Apr;22(7):554-72. doi: 10.1053/euhj.2001.2610.
4
Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial.针对冠心病患者和心血管疾病高危无症状个体的护士协调多学科家庭式心血管疾病预防项目(EUROACTION):一项配对、整群随机对照试验。
Lancet. 2008 Jun 14;371(9629):1999-2012. doi: 10.1016/S0140-6736(08)60868-5.
5
ESH-ESC guidelines for the management of hypertension.欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)高血压管理指南
Herz. 2006 Jun;31(4):331-8. doi: 10.1007/s00059-006-2829-3.
6
[The PreFord Study. A prospective cohort study to evaluate the risk of a cardiovascular event (overall-collective) as well as a prospective, randomized, controlled, multicentre clinical intervention study (high-risk-collective) on primary prevention of cardiovascular diseases in the Ford Motor Company employees in Germany].[普瑞福特研究。一项评估心血管事件风险(总体人群)的前瞻性队列研究,以及一项针对德国福特汽车公司员工心血管疾病一级预防的前瞻性、随机、对照、多中心临床干预研究(高危人群)]
Z Kardiol. 2004 Feb;93(2):131-6. doi: 10.1007/s00392-004-0990-3.
7
Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.预测5年内心血管疾病和中风的人群水平风险降低对急性住院率的影响——一项试点研究。
Public Health. 2006 Dec;120(12):1140-8. doi: 10.1016/j.puhe.2006.10.012. Epub 2006 Nov 3.
8
Effects of a general practice-based intervention on diet, body mass index and blood lipids in patients at cardiovascular risk.一项基于全科医疗的干预措施对心血管疾病风险患者饮食、体重指数和血脂的影响。
J Cardiovasc Risk. 2003 Feb;10(1):31-40. doi: 10.1097/01.hjr.0000050718.61003.30.
9
EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.欧洲动脉粥样硬化调查III:对来自22个欧洲国家的冠心病患者的生活方式、风险因素及心脏保护药物治疗使用情况的调查。
Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):121-37. doi: 10.1097/HJR.0b013e3283294b1d.
10
Workplace-based cardiovascular risk management by community pharmacists: impact on blood pressure, lipid levels, and weight.社区药剂师在工作场所进行的心血管风险管理:对血压、血脂水平和体重的影响。
Pharmacotherapy. 2006 Oct;26(10):1511-7. doi: 10.1592/phco.26.10.1511.